CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage
The CDC's move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise in some parts of the country.
Source link
/cloudfront-us-east-2.images.arcpublishing.com/reuters/VEEKMZ3UZJP7ZNGSTTUKIIRZFA.jpg "‘Ashamed’: Pakistan grapples with fallout from mob killing")
